Pfizer Inc. (PFE)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on Pfizer Inc. (PFE)
563 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on PFE
- SA Editor Miriam Metzinger(53)
- Mike Huckman(47)
- Derek Lowe(31)
- Bespoke Investment Group(31)
- SA Editor Eli Hoffmann(29)
Most popular authors
(tracked in watchlists)
- David Fry(1197)
- Philip Davis(722)
- Bespoke Investment Group(661)
- Trader Mark(624)
- Bill Cara(481)
Most commented on authors
- Bespoke Investment Group(138)
- Mike Huckman(111)
- SA Editor Eli Hoffmann(105)
- Devin Hobbes(101)
- Mike Stathis (101)
- 30 Stocks Worth Investigating for 2009
- Fast Money Recap - Bullish on Biotech (1/5/09)
- Hedge Fund Tracking: Farallon Capital Management (Thomas Steyer), Q3 2008
- Pharma ETF: Investment Stability In an Unstable World
- Is Pfizer Now Interested in a Merger?
- How Will Fortune Magazine's 10 Stock Picks for 2009 Fare?
- Wall Street Breakfast: Must-Know News
- Dow Dogs Were Dogs in 2008, What About 2009?
- Fast Money Recap - Trading the Times Square Ball (12/30/08)
- Dividends Stocks: Refining Risk Measurement
- Pfizer: A Case Study of the Market's Extremely Low Valuations
- Drugmakers See Healthy Profits on Flu Pandemic Watch
- Is There a Legitimate Case for the Healthcare Providers ETF?
- 3 Dividend Aristocrats in Danger of Losing Their Status
- Hedge Fund Tracking: Barry Rosenstein's Jana Partners, Q3 2008
- Five Things Worth Remembering About Healthcare in 2009
- Best Stocks for 2009
- Good Bye U.S. Savings Bonds, Hello Stem Cells, Farmland and India
- S&P's 2009 Dividend Aristocrats: Who Made the Cut?
- 40 Top Rated Emerging Bio-Pharma Stocks
- Dogs Will Be Dogs
- Pfizer Gives Sangamo a Vote of Confidence
- Stem Cell and Regenerative Medicine Stocks Surge in December
- Healthcare: Investing Trends for 2009
- Study Says Price Controls Bad for Drug Firms and Consumers
- Pfizer Ends 40 Year Run of Hiking Dividends
- Recession-Proof? The Beauty of Big Pharma Is in the Eye of the Beholder
- Pfizer's Restructuring Still Leaves Employees in the Dark
- The Dogs of the Dow Can Keep You Out of the Doghouse
- Strong Dollar's Impact on Pharma vs. Generics
- Cytori Therapeutics and Cypress Bio: Two Buys Based on Positive Trial Results
- Investment Ideas That Stand Out from ETF Innovators New Indexes
- Johnson & Johnson Steals Mentor Corp.: Who's Next?
- Fast Money Recap - Is Pharma Healthy? (12/3/08)
- Surprise, Pfizer Study Says Lipitor Beats Generic Zocor
- Poor Strategy Is Costly
- More Focused Defensive Index
- Short Interests in Pfizer and Dendreon Decline - Is Bearish Sentiment Dissipating?
- Will Merck's Atherosclerosis Drug Fare Better Than Pfizer's Did?
- Dividend Aristocrats Outperform in November
- Thanksgiving Economic Data: Mostly Turkeys
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »
16 new today)